With EUR 56m investment, Krka doubles R&D capacities

Novo Mesto, 1 October - Krka, the Novo Mesto-seated pharmaceuticals group, has launched a new research and development centre to nearly double its R&D, and control and analysis capacities.

Novo Mesto The management of pharmaceuticals company Krka presents a new R&D centre which almost doubles its R&D and control and analysis capacities. Photo: Rasto Božič/STA

Novo Mesto
The management of pharmaceuticals company Krka presents a new R&D centre which almost doubles its R&D and control and analysis capacities.
Photo: Rasto Božič/STA

Novo Mesto Krka director general Jože Colarič. Photo: Rasto Božič/STA

Novo Mesto
Krka director general Jože Colarič.
Photo: Rasto Božič/STA

The rest of this news item is available to subscribers.
The news item consists of 1.538 characters (without spaces) or 304 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

aaz/eho/rbo/ep/ep
© STA, 2019

The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.

I want to know more